224 related articles for article (PubMed ID: 16864840)
21. Vanishing white matter disease in French-Canadian patients from Quebec.
Robinson MÈ; Rossignol E; Brais B; Rouleau G; Arbour JF; Bernard G
Pediatr Neurol; 2014 Aug; 51(2):225-32. PubMed ID: 25079571
[TBL] [Abstract][Full Text] [Related]
22. Leukoencephalopathy with vanishing white matter:: an adult onset case.
Biancheri R; Rossi A; Di Rocco M; Filocamo M; Pronk JC; van der Knaap MS; Tortori-Donati P
Neurology; 2003 Dec; 61(12):1818-9. PubMed ID: 14694060
[No Abstract] [Full Text] [Related]
23. [Association between homozygous c.318A>GT mutation in exon 2 of the EIF2B5 gene and the infantile form of vanishing white matter leukoencephalopathy].
Esmer C; Blanco Hernández G; Saavedra Alanís V; Reyes Vaca JG; Bravo Oro A
Bol Med Hosp Infant Mex; 2017; 74(5):364-369. PubMed ID: 29382480
[TBL] [Abstract][Full Text] [Related]
24. Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
Passemard S; Gelot A; Fogli A; N'Guyen S; Barnerias C; Niel F; Doummar D; Arbues AS; Mignot C; de Villemeur TB; Ponsot G; Boespflug-Tanguy O; Rodriguez D
Neurology; 2007 Jul; 69(4):400-2. PubMed ID: 17646634
[No Abstract] [Full Text] [Related]
25. Early MR imaging and spectroscopy appearance of eIF2B-related leukoencephalopathy.
Mascalchi M; De Grandis D; Ginestroni A; Pratesi A; Della Nave R; Scheper GC; van der Knaap MS
Neurology; 2006 Aug; 67(3):537-8. PubMed ID: 16894129
[No Abstract] [Full Text] [Related]
26. Vanishing white matter disease with mutations in EIF2B5 gene.
Sharma S; Ajij M; Singh V; Aneja S
Indian J Pediatr; 2015 Jan; 82(1):93-5. PubMed ID: 25230711
[TBL] [Abstract][Full Text] [Related]
27. Novel mutations identified in EIF2B5 gene in Kashmiri patients as susceptibility factor for multiple sclerosis.
Zahoor I; Hamid Z; Asimi R; Haq E
Indian J Biochem Biophys; 2014 Apr; 51(2):115-20. PubMed ID: 24980014
[TBL] [Abstract][Full Text] [Related]
28. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
[TBL] [Abstract][Full Text] [Related]
29. Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations.
Lee HN; Koh SH; Lee KY; Ki CS; Lee YJ
Eur J Neurol; 2009 Mar; 16(3):e42-3. PubMed ID: 19170749
[No Abstract] [Full Text] [Related]
30. Vanishing white matter disease associated with progressive macrocephaly.
Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC
Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679
[TBL] [Abstract][Full Text] [Related]
31. SOX10 mutation with peripheral amyelination and developmental disturbance of axons.
Parthey K; Kornhuber M; Kunze C; Wand D; Nolte KW; Nikolin S; Weis J; Schröder JM
Muscle Nerve; 2012 Feb; 45(2):284-90. PubMed ID: 22246888
[TBL] [Abstract][Full Text] [Related]
32. Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
Horzinski L; Gonthier C; Rodriguez D; Scherer C; Boespflug-Tanguy O; Fogli A
Ann Hum Genet; 2008 May; 72(Pt 3):410-5. PubMed ID: 18294360
[TBL] [Abstract][Full Text] [Related]
33. Polymicrogyria and motor neuropathy in Micro syndrome.
Nassogne MC; Henrot B; Saint-Martin C; Kadhim H; Dobyns WB; Sébire G
Neuropediatrics; 2000 Aug; 31(4):218-21. PubMed ID: 11071150
[TBL] [Abstract][Full Text] [Related]
34. Non-eIF2B-related cystic leukoencephalopathy of unknown origin.
van der Knaap MS; Scheper GC
Ann Neurol; 2006 Apr; 59(4):724. PubMed ID: 16566013
[No Abstract] [Full Text] [Related]
35. Genotype-phenotype correlation in vanishing white matter disease.
van der Lei HD; van Berkel CG; van Wieringen WN; Brenner C; Feigenbaum A; Mercimek-Mahmutoglu S; Philippart M; Tatli B; Wassmer E; Scheper GC; van der Knaap MS
Neurology; 2010 Oct; 75(17):1555-9. PubMed ID: 20975056
[TBL] [Abstract][Full Text] [Related]
36. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.
Dietrich J; Lacagnina M; Gass D; Richfield E; Mayer-Pröschel M; Noble M; Torres C; Pröschel C
Nat Med; 2005 Mar; 11(3):277-83. PubMed ID: 15723074
[TBL] [Abstract][Full Text] [Related]
37. Vanishing white matter disease: a review with focus on its genetics.
Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS
Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905
[TBL] [Abstract][Full Text] [Related]
38. Where has all the white matter gone? Unraveling the mysteries of leukoencephalopathies.
Kaye EM; Moser H
Neurology; 2004 May; 62(9):1464-5. PubMed ID: 15136665
[No Abstract] [Full Text] [Related]
39. No evidence for association between the EIF2B5 gene and multiple sclerosis in French families.
Fogli A; Barbier C; Cournu-Rebeix I; Babron MC; Clerget-Darpoux F; Fontaine B; Boespflug-Tanguy O
Mult Scler; 2008 May; 14(4):573. PubMed ID: 18562513
[No Abstract] [Full Text] [Related]
40. Phenotypic variability in giant axonal neuropathy.
Tazir M; Nouioua S; Magy L; Huehne K; Assami S; Urtizberea A; Grid D; Hamadouche T; Rautenstrauss B; Vallat JM
Neuromuscul Disord; 2009 Apr; 19(4):270-4. PubMed ID: 19231187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
